Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry, v3.3.4, was added to the Record History, replacing v3.3.3; this appears to be a minor administrative update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:38.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T20:24:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Two new history entries were added (Study Status on 2025-12-15 and version 33 on 2025-12-10), and the 2025-07-30 entry was removed.
    Difference
    0.3%
    Check dated 2025-12-16T15:23:30.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.2, replacing v3.2.0. This is a system version update and does not alter trial details or records.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:54.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The funding-delay notice on the page was removed, eliminating guidance about data currency during government funding gaps. This may reduce visibility into the page's reliability context for updates.
    Difference
    0.5%
    Check dated 2025-11-17T20:05:55.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Both screenshots show the same Record History page for NCT03131908 with identical version entries and controls; any differences appear to be visual/UI adjustments rather than content updates.
    Difference
    0.1%
    Check dated 2025-11-03T13:49:11.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.